Skip to content

PHARMANATUUR

Active
Private limited companyfounded 2022active for 4 yearsDaalstraat 34, 1790 Affligem, BelgiumKBO/BCE: BE 0791.769.428
Summary

The computed 12-month bankruptcy probability of PHARMANATUUR is 15.8% (high). The 2023 annual accounts show negative equity (-€25,815) and a net result of -€35,815. Its solvency ranks better than 11% of 23,998 sector peers (NACE 47, financial year 2023). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
PHARMANATUURActive
Risk analysis ReportCompare

Financials · financial year 2023, micro format

2023 annual accounts filed late (19 days) Filed on 19 August 2024, deadline 31 July 2024 (7 months after the close on 31 December 2023, Companies Code art. 3:10). Source: NBB, 2024-00349628.

Equity
-€25,815
Total assets
€51,561
Net result
-€35,815
Working capital
-€29,169

Turnover and EBIT margin not published: the micro format does not require them.

Balance-sheet composition
Assets €51,561
Fixed assets €12,485
Current assets €39,075
Equity and liabilities
Equity-€25,815
Debt€77,376
Equity is negative: debt (€77,376) exceeds the balance-sheet total (€51,561).
Key figures and ratios
2023 value
EBITDA
-€31,817
Cash flow
-€33,948
Solvency
-50.1%
Current ratio
0.57
Quick ratio
0.11
ROA
-69.5%
Interest coverage
-14.91
Debt
€77,376
Debt ≤ 1 year
€68,244
Debt > 1 year
€9,131
Staff costs
€5,579
No debt to equity: equity is negative, so debt divided by equity means nothing.
Annual accounts
Filed annual accounts As filed with the NBB · 2023 · 41 lines
Balance sheet Code2023
Assets
Total assets20/58€51,561
Fixed assets21/28€12,485
Tangible fixed assets22/27€10,640
Plant, machinery and equipment23€9,871
Furniture and vehicles24€769
Financial fixed assets28€1,845
Current assets29/58€39,075
Stocks and contracts in progress3€31,229
Stocks30/36€31,229
Amounts receivable within one year40/41€2,883
Trade receivables40€2,767
Other amounts receivable41€116
Cash at bank and in hand54/58€4,339
Deferred charges and accrued income490/1€624
Equity and liabilities
Total equity and liabilities10/49€51,561
Equity10/15-€25,815
Contributions10/11€10,000
Profit (loss) carried forward14-€35,815
Amounts payable17/49€77,376
Amounts payable after more than one year17€9,131
Financial debts170/4€9,131
Amounts payable within one year42/48€68,244
Current portion of amounts payable after more than one year42€17,226
Trade debts44€5,175
Suppliers440/4€5,175
Taxes, remuneration and social security45€641
Remuneration and social security454/9€641
Other amounts payable47/48€45,202
Income statement Code2023
Remuneration, social security and pensions62€5,579
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,867
Other operating charges640/8€554
Gross operating margin9900-€25,685
Operating profit (loss)9901-€33,684
Financial income75/76B€3
Recurring financial income75€3
Financial charges65/66B€2,134
Recurring financial charges65€2,134
Profit (loss) for the period before taxes9903-€35,815
Profit (loss) for the period9904-€35,815
Profit (loss) for the period to be appropriated9905-€35,815
Appropriation of the result
Profit (loss) to be appropriated9906-€35,815

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2023
Remuneration, social security and pensions62€5,579
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,867
Other operating charges640/8€554
Gross operating margin9900-€25,685
Operating profit (loss)9901-€33,684
Financial income75/76B€3
Recurring financial income75€3
Financial charges65/66B€2,134
Recurring financial charges65€2,134
Profit (loss) for the period before taxes9903-€35,815
Profit (loss) for the period9904-€35,815
Profit (loss) for the period to be appropriated9905-€35,815
Line2023
Assets
Total assets20/58€51,561
Fixed assets21/28€12,485
Tangible fixed assets22/27€10,640
Plant, machinery and equipment23€9,871
Furniture and vehicles24€769
Financial fixed assets28€1,845
Current assets29/58€39,075
Stocks and contracts in progress3€31,229
Stocks30/36€31,229
Amounts receivable within one year40/41€2,883
Trade receivables40€2,767
Other amounts receivable41€116
Cash at bank and in hand54/58€4,339
Deferred charges and accrued income490/1€624
Equity and liabilities
Total equity and liabilities10/49€51,561
Equity10/15-€25,815
Contributions10/11€10,000
Profit (loss) carried forward14-€35,815
Amounts payable17/49€77,376
Amounts payable after more than one year17€9,131
Financial debts170/4€9,131
Amounts payable within one year42/48€68,244
Current portion of amounts payable after more than one year42€17,226
Trade debts44€5,175
Suppliers440/4€5,175
Taxes, remuneration and social security45€641
Remuneration and social security454/9€641
Other amounts payable47/48€45,202
Line2023
Profit (loss) for the period9904-€35,815
+ Depreciation and write-downs630€1,867
Operating cash flow (approximation)-€33,948

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (1)
Financial year Type Filed Reference
31-12-2023 micro format 19-08-2024 2024-00349628

Similar companies · same sector and region

ACP-PHARMA
BE 1018.630.058
Affligem
APOTHEEK ESSENE
BE 0426.504.545
Affligem
APOTHEEK LIBENS-VAN TICHELEN
BE 0862.339.007
Affligem
APOTHEEK VAN DESSEL
BE 0776.365.432
Affligem
BVV
BE 0760.315.494
Affligem
This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 5,204 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,907. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

We would like to set cookies. That happens only with your consent. What we measure